Bioequivalent versions of branded antimigraine medications, including triptans and ergotamines, produced by generic manufacturers. Supplied to pharmaceutical distributors, hospital pharmacies, and retail chains for procurement by clinicians treating headache disorders in outpatient and inpatient settings.